Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Bansilal

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|April 9, 2016
Family-Based Approaches to Cardiovascular Health PromotionRajesh Vedanthan, Sameer Bansilal, Ana Victoria Soto, et al.
Circulation. Cardiovascular Interventions|July 23, 2015
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY TrialsDaniele Giacoppo, Mahesh V Madhavan, Usman Baber, et al.
JAMA Cardiology|June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With FinerenoneRajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
American Heart Journal|April 30, 2017
Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA)Sameer Bansilal, Rajesh Vedanthan, Jason C Kovacic, et al.
Journal of the American College of Cardiology|April 27, 2019
Child Health Promotion in Underserved Communities: The FAMILIA TrialRodrigo Fernandez-Jimenez, Risa Jaslow, Sameer Bansilal, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
The American Journal of Cardiology|May 17, 2016
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI TrialsGennaro Giustino, Roxana Mehran, Sameer Bansilal, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|April 28, 2009
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular eventsVenkatesh Mani, Paul Muntner, Samuel S Gidding, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|April 9, 2016
Family-Based Approaches to Cardiovascular Health PromotionRajesh Vedanthan, Sameer Bansilal, Ana Victoria Soto, et al.
Circulation. Cardiovascular Interventions|July 23, 2015
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY TrialsDaniele Giacoppo, Mahesh V Madhavan, Usman Baber, et al.
JAMA Cardiology|June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With FinerenoneRajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
American Heart Journal|April 30, 2017
Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA)Sameer Bansilal, Rajesh Vedanthan, Jason C Kovacic, et al.
Journal of the American College of Cardiology|April 27, 2019
Child Health Promotion in Underserved Communities: The FAMILIA TrialRodrigo Fernandez-Jimenez, Risa Jaslow, Sameer Bansilal, et al.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
The American Journal of Cardiology|May 17, 2016
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI TrialsGennaro Giustino, Roxana Mehran, Sameer Bansilal, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|April 28, 2009
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular eventsVenkatesh Mani, Paul Muntner, Samuel S Gidding, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
Pageof 8